149 related articles for article (PubMed ID: 29890464)
1. ZNF750 inhibited the malignant progression of oral squamous cell carcinoma by regulating tumor vascular microenvironment.
Pan L; Yang H; Xu C; Chen S; Meng Z; Li K; Chen H
Biomed Pharmacother; 2018 Sep; 105():566-572. PubMed ID: 29890464
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol suppresses malignant progression of oral squamous cell carcinoma cells by inducing the ZNF750/RAC1 signaling pathway.
Xiao Y; Duan Y; Wang Y; Yin X
Bioengineered; 2021 Dec; 12(1):2863-2873. PubMed ID: 34176441
[TBL] [Abstract][Full Text] [Related]
3. [Function and mechanism of zinc finger protein ZNF50 in inhibiting the growth of esophageal squamous cell carcinoma cells].
Wang J; Bi YH; Yang J; Liu F; Li YK; Cui HY; Wang F; Liu J; Yang B; Zhang L
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):7-12. PubMed ID: 28104026
[No Abstract] [Full Text] [Related]
4. ZNF750 is a lineage-specific tumour suppressor in squamous cell carcinoma.
Hazawa M; Lin DC; Handral H; Xu L; Chen Y; Jiang YY; Mayakonda A; Ding LW; Meng X; Sharma A; Samuel S; Movahednia MM; Wong RW; Yang H; Tong C; Koeffler HP
Oncogene; 2017 Apr; 36(16):2243-2254. PubMed ID: 27819679
[TBL] [Abstract][Full Text] [Related]
5. RUNX3 plays a tumor suppressor role by inhibiting cell migration, invasion and angiogenesis in oral squamous cell carcinoma.
Zhou WN; Du YF; Bai J; Song XM; Zheng Y; Yuan H; Zhang W; Zhang ZD; Wu YN
Oncol Rep; 2017 Oct; 38(4):2378-2386. PubMed ID: 28765934
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of tumor suppressor gene ZNF750 inhibits oral squamous cell carcinoma metastasis.
Yang H; Pan L; Xu C; Zhang Y; Li K; Chen S; Zhang B; Liu Z; Wang LX; Chen H
Oncol Lett; 2017 Nov; 14(5):5591-5596. PubMed ID: 29113187
[TBL] [Abstract][Full Text] [Related]
7. RNA sequencing analysis of the CAL-27 cell response to over-expressed ZNF750 gene revealed an extensive regulation on cell cycle.
Liu X; Yang Y; Xu C; Yang H; Chen S; Chen H
Biomed Pharmacother; 2019 Oct; 118():109377. PubMed ID: 31545271
[TBL] [Abstract][Full Text] [Related]
8. Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.
Harada K; Supriatno ; Yoshida H; Sato M
Int J Oncol; 2005 Dec; 27(6):1489-97. PubMed ID: 16273203
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis.
Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R
Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-β signals promote progression of squamous cell carcinoma by inducing epithelial-mesenchymal transition and angiogenesis.
Ibi H; Takahashi K; Harada H; Watabe T; Podyma-Inoue KA
Biochem Biophys Res Commun; 2024 Jun; 714():149965. PubMed ID: 38657447
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical Expression of CD105 and TGF-β1 in Oral Squamous Cell Carcinoma and Adjacent Apparently Normal Oral Mucosa and its Correlation With Clinicopathologic Features.
Nair S; Nayak R; Bhat K; Kotrashetti VS; Babji D
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):35-41. PubMed ID: 25710582
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of aberrantly expressed nuclear localized decorin attenuates tumour angiogenesis related mediators in oral cancer progression model in vitro.
Dil N; Banerjee AG
Head Neck Oncol; 2012 Jun; 4():11. PubMed ID: 22507529
[TBL] [Abstract][Full Text] [Related]
13. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
Arora S; Kaur J; Sharma C; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Clin Cancer Res; 2005 Mar; 11(6):2272-84. PubMed ID: 15788677
[TBL] [Abstract][Full Text] [Related]
14. miR-320 regulates tumor angiogenesis driven by vascular endothelial cells in oral cancer by silencing neuropilin 1.
Wu YY; Chen YL; Jao YC; Hsieh IS; Chang KC; Hong TM
Angiogenesis; 2014 Jan; 17(1):247-60. PubMed ID: 24114198
[TBL] [Abstract][Full Text] [Related]
15. Semaphorin 4A restricts tumor progression by inhibiting angiogenesis of oral squamous cell carcinoma cells.
Liu XQ; Yao Y; Mu JW; Yang FY
Tissue Cell; 2021 Apr; 69():101485. PubMed ID: 33460983
[TBL] [Abstract][Full Text] [Related]
16. Eldecalcitol (ED-71), an analog of 1α,25(OH)
Shintani T; Takatsu F; Rosli SNZ; Usui E; Hamada A; Sumi K; Hayashido Y; Toratani S; Okamoto T
In Vitro Cell Dev Biol Anim; 2017 Oct; 53(9):810-817. PubMed ID: 28710602
[TBL] [Abstract][Full Text] [Related]
17. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
Shang ZJ; Li JR
J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor 936 C/T polymorphism is associated with vascular invasion in oral squamous cell carcinoma.
Cheng CY; Chang CS; Liu CJ; Kao SY
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jul; 106(1):79-84. PubMed ID: 18299215
[TBL] [Abstract][Full Text] [Related]
19. Expression level of vascular endothelial growth factor-C and -A in cultured human oral squamous cell carcinoma correlates respectively with lymphatic metastasis and angiogenesis when transplanted into nude mouse oral cavity.
Nakazato T; Shingaki S; Kitamura N; Saito C; Kuwano R; Tachibana M
Oncol Rep; 2006 Apr; 15(4):825-30. PubMed ID: 16525666
[TBL] [Abstract][Full Text] [Related]
20. Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia.
Shimanishi M; Ogi K; Sogabe Y; Kaneko T; Dehari H; Miyazaki A; Hiratsuka H
J Oral Pathol Med; 2013 May; 42(5):382-8. PubMed ID: 23227892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
